Cancer
chemotherapy
is the use of drugs to kill cancer cells. Unlike
radiation
and surgery, which are localized treatments, chemotherapy is a systemic treatment, meaning the drugs travel throughout the whole body. This means chemotherapy can reach cancer cells that may have spread (metastasized) to other areas.
Chemotherapy is not commonly used for endometrial cancer. The treatment may be ordered for Stage IV disease, when the cancer has spread to other parts of the body, or if the disease recurs. The drugs are often given in combination and in cycles. All of these drugs are given intravenously at the doctor’s office or in the hospital.
- Cisplatin
- Cyclophosphamide
(Cytoxan)
- Doxorubicin
(Adriamycin)
- Carboplatin
- Paclitaxel
- Ifosfamide
Combination chemotherapy
regimens used in uterine cancer include:
- CAP (Cyclophosphamide, Adriamycin, Cisplatin)
- Cisplatin and doxorubicin
- Cyclophosphamide and doxorubicin
- Carboplatin and Paclitaxel
Doctors have yet to find a chemotherapy regimen that is curative or highly effective for advanced or recurrent uterine cancer. In various studies, the response rates to chemotherapy range from 36% to 67%. However, even in patients who respond to treatment, the response lasts only four to eight months on average.
Chemotherapy is sometimes combined with hormonal therapy for the treatment of advanced or recurrent uterine cancer.
Last reviewed September 2011 by Igor Puzanov, MD
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Publishing. All rights reserved.